Showing results (2081-2090 of 8,887) with videos related to

Sort By:
Pageof 889
European Urology|July 27, 2023
Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial CarcinomaThomas Powles, Zoe June Assaf, Viraj Degaonkar, et al.
European Urology|May 28, 2023
Germline Exome Sequencing for Men with Testicular Germ Cell Tumor Reveals Coding Defects in Chromosomal Segregation and Protein-targeting GenesLouise C Pyle, Jung Kim, Jonathan Bradfield, et al.
European Urology|May 14, 2024
The Role of Microsatellite Instability/DNA Mismatch Repair Deficiency and Tumor Mutational Burden as Biomarkers in Predicting Response to Immunotherapy in Castration-resistant Prostate CancerNiklas Klümper, Viktor Grünwald, Arndt Hartmann, et al.
European Urology|April 25, 2024
Improving Patient Information and Enhanced Consent in Urology: The Impact of Simulation and Multimedia Tools. A Systematic Literature Review from the European Association of Urology Patient OfficeCarlotta Nedbal, Patrick Juliebø-Jones, Eamonn Rogers, et al.
European Urology|April 6, 2024
Characterization of Responses to Lenvatinib plus Pembrolizumab in Patients with Advanced Renal Cell Carcinoma at the Final Prespecified Survival Analysis of the Phase 3 CLEAR StudyRobert J Motzer, Toni K Choueiri, Thomas Hutson, et al.
European Urology|April 9, 2024
Summary of the 2024 Update of the European Association of Urology Guidelines on NeurourologyAndrea M Sartori, Thomas M Kessler, David M Castro-Díaz, et al.
European Urology|October 27, 2023
Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 StudyRenu S Eapen, James P Buteau, Price Jackson, et al.
European Urology|September 13, 2023
Early Detection of Prostate Cancer in the European Union: Combining Forces with PRAISE-UHendrik Van Poppel, Monique J Roobol, Arunah Chandran
European Urology|April 9, 2026
Prognostic Value of Interim PSMA-PET Total Tumor Volume for Overall Survival Within ENZA-p, A Randomized Phase 2 Trial of Enzalutamide Versus Enzalutamide Plus [177Lu] Lu-PSMA-617 (ANZUP1901)Louise Emmett, Nathan Papa, Oliver Sartor, et al.
European Urology|April 22, 2026
Safety and Efficacy of Tranexamic Acid in Urologic Surgery: Results from the International, Randomized, Placebo-Controlled POISE-3 TrialKari A O Tikkinen, Maura Marcucci, Alex L E Halme, et al.
Pageof 889